Development of a selective activity-based probe for glycosylated LIPA.

Bioorg Med Chem Lett

Worldwide Medicinal Chemistry, Pfizer Pharmatherapeutics Research and Development, Cambridge, MA 02143, United States.

Published: April 2016

Loss of LIPA activity leads to diseases such as Wolman's Disease and Cholesterol Ester Storage Disease. While it is possible to measure defects in LIPA protein levels, it is difficult to directly measure LIPA activity in cells. In order to measure LIPA activity directly we developed a LIPA specific activity based probe. LIPA is heavily glycosylated although it is unclear how glycosylation affects LIPA activity or function. Our probe is specific for a glycosylated form of LIPA in cells, although it labels purified LIPA regardless of glycosylation.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2016.02.089DOI Listing

Publication Analysis

Top Keywords

lipa activity
16
lipa
10
measure lipa
8
activity
5
development selective
4
selective activity-based
4
activity-based probe
4
probe glycosylated
4
glycosylated lipa
4
lipa loss
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!